Here are 14 key notes on major spine and orthopedic device companies.
Biomet released preliminary financial results for the fourth quarter and full 2014 fiscal year and its consolidated net sales increased 7.7 percent to $844.5 million worldwide over the same period last year.
More than two months after Zimmer announced intentions to acquire Biomet, the United States Federal Trade Commission requested additional information on the companies.
Integra LifeSciences established new terms under its credit facility, including an extended maturity state.
NuVasive will participate in the 21st International Meeting on Advanced Spine Techniques on July 16 to 21 in Spain.
Device company Paradigm Spine published two separate independent prospective clinical studies that examine the short- and long-term durability of coflex interlaminar stabilization.
Stryker's Director Ronda E. Stryker sold 14,000 shares of the company on July 3. She has sold around 21,000 shares this month so far.
Medtronic plans to cut 40 jobs in Minnesota.
Stryker sold its bone morphogenetic protein-7 assets to Mariel Therapeutics.
Benvenue Medical named 20-year industry veteran Jeffrey Jones COO.
Munich Innovation, based in Germany, plans to sell the Magnetodyn patented portfolio of bone and tissue regeneration technology.
NuVasive named Carol Cox executive vice president of strategy and corporate communications, reporting directly to chairman and CEO Alex Lukianov.
MicroPort Orthopedics and MB Innovations entered into a multi-product development agreement for orthopedic instruments.
Exactech Executive Vice President Gary J. Miller sold 12,392 more shares of the company's stock.
Spine device company NuVasive plans to open an international operations center in Waterford, Ireland.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018